texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

CHRISTUS Health and Texas Oncology-Tyler Open New Cancer Treatment & Research Institute

Tyler, TX, November 29, 2022 – CHRISTUS Health and Texas Oncology announced today the opening of the new, innovative Northeast Texas Cancer and Research Institute at 501 S. Saunders Ave. in Tyler, Texas, a major step forward in enhancing and expanding cancer care in northeast Texas. The center’s first patients received leading-edge treatment and oncology services this month.

The new 85,000-square-foot center, a collaboration between CHRISTUS Health and Texas Oncology, features specialized areas for Texas Oncology–Tyler, including clinic space for medical oncology, hematology, gynecologic oncology, radiation oncology, and nearly 3,000 square feet of dedicated clinical research space. The Institute also provides patients with access to cancer prevention services, diagnostic screenings, and a comprehensive genetic risk evaluation program. The center has three linear accelerators for radiation therapy, 52 chemotherapy infusion stations, including six dedicated to research, and four private rooms. The center also provides patients access to Texas Oncology’s on-site pharmacy, laboratory services, and an exercise area.

Within the Institute, CHRISTUS Health houses a 7,500-square-foot advanced imaging center with 3T MRI, PET/CT, CT, ultrasound, nuclear medicine and more. An additional 10,000 square feet of CHRISTUS Health clinic space supports the surgical oncology program of Louise Herrington Cancer Center. Opened in 2020, Louise Herrington Cancer Center is an inpatient facility located within CHRISTUS Mother Frances Hospital - Tyler providing state-of-the-art, inpatient care for complex cancer patients.

“Tyler area cancer patients have benefitted from our successful collaboration with Texas Oncology for more than 25 years, with a wonderful clinic on our NorthPark campus. This Institute is a significant advancement for the people of Northeast Texas,” said Chris Glenney, FACHE, Chief Executive Officer, CHRISTUS Health Northeast Texas. “We are constantly working to provide better cancer care to our patients, and one of the most effective ways to do that is to have great relationships and great teams.”

“The combination of Texas Oncology’s decades of experience in delivering leading-edge cancer care in communities across the state and the inpatient care offered by CHRISTUS Health will continue to meet the comprehensive and varied cancer care needs of this region,” said Steven Paulson, M.D., president and chairman of the board, Texas Oncology. “It matters that patients can get needed treatment here – including leading edge therapies through clinical trials – with critical support from family, friends, and coworkers close by.”

The new Institute also enhances Tyler’s leadership in groundbreaking cancer research. At Texas Oncology–Tyler, a robust clinical trials and research program has helped in the development of major cancer breakthroughs like immunotherapy drugs such as Opdivo® and Keytruda®. Texas Oncology–Tyler has offered more than 550 clinical trials in which more than 8,100 area patients have participated.

“We have come together to create clinical programs that improve care for our patients, further expand upon Texas Oncology’s significant research projects, and ultimately create opportunities to grow cancer services throughout northeast Texas. That’s a big part of the vision for cancer care for Texas Oncology,” said Mark Saunders, M.D., radiation oncologist, co-founder of Texas Oncology–Tyler, and East Texas regional medical director for Texas Oncology.

“Alongside this talented team of physicians, advanced practice providers, nurses, and Associates, we will work collegially and collaboratively to provide state-of-the-art care and innovative services for cancer patients,” Steven Curley, M.D., FACS, Institute Chair, CHRISTUS Trinity Mother Frances Oncology Institute. “We are proud of the many years of collaboration with our colleagues at Texas Oncology–Tyler in delivering the full spectrum of leading-edge cancer care.”

“Patients have access to exceptional cancer care in their own backyard,” said Glenney. “As caregivers, we understand the importance of being close to home, near loved ones when facing something as challenging and life-changing as cancer. Northeast Texas Cancer and Research Institute is here to provide a full suite of high-level cancer care options right here in Tyler.”

About Christus Health

At CHRISTUS Health, we deliver a complete healing experience that respects the individual. We serve our communities with dignity. And with a good deal of admiration. CHRISTUS Health is a Catholic, not- for-profit system made up of more than 600 centers, including long-term care facilities, community hospitals, walk-in clinics and health ministries. We are a community 45,000 strong, with over 15,000 physicians providing individualized care. Sponsored by the Sisters of Charity of the Incarnate Word in Houston and San Antonio and the Sisters of the Holy Family of Nazareth, our mission is to extend the healing ministry of Jesus Christ to every individual we serve.

About Texas Oncology

Texas Oncology is an independent private practice with more than 525 physicians and 220 locations. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Colon and Rectal Specialists, Texas Oncology Surgical Specialists, Texas Urology Specialists, Texas Infusion & Imaging Center, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies. For more information, visit TexasOncology.com.

Related Cancer Centers